• Price (--)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Clover Health Investments, Corp. is a healthcare technology company. The Company’s segments include Medicare Advantage (MA) and Direct Contracting (DC). The MA segment is an insurance business model that focuses on leveraging the Clover Assistant at the point of care. The Company’s DC segment is similar to the cost management and care coordination model accounted for as a performance guarantee, where Clover is responsible for coordinating care, managing costs, and providing support to providers and their direct contracting entity (DCE) beneficiaries through the use of Clover Assistant. It offers a software platform called the Clover Assistant, which provides America’s seniors with Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans that are the obvious choice for Medicare-eligible consumers. The Clover Assistant is a technology platform that engages providers and delivers data-driven and personalized care. It operates its MA plans in over nine states.

  • Revenue in USD (TTM)2.15bn
  • Net income in USD-614.65m
  • Incorporated2021
  • Employees680.00
  • Location
    Clover Health Investments Corp3401 Mallory Lane, Suite 210, Suite 320FRANKLIN 37067United StatesUSA
  • Phone+1 (201) 432-2133
  • Fax+1 (302) 655-5049
  • Websitehttps://www.cloverhealth.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.